Compare PROV & TMCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PROV | TMCI |
|---|---|---|
| Founded | 1956 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 103.7M | 120.4M |
| IPO Year | 2009 | 2021 |
| Metric | PROV | TMCI |
|---|---|---|
| Price | $17.25 | $2.80 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 2 | 6 |
| Target Price | ★ $16.25 | $4.77 |
| AVG Volume (30 Days) | 5.8K | ★ 499.4K |
| Earning Date | 04-28-2026 | 05-08-2026 |
| Dividend Yield | ★ 3.26% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.68 | N/A |
| Revenue | N/A | ★ $212,690,000.00 |
| Revenue This Year | $4.14 | N/A |
| Revenue Next Year | $3.70 | $8.18 |
| P/E Ratio | $25.31 | ★ N/A |
| Revenue Growth | N/A | ★ 1.59 |
| 52 Week Low | $14.95 | $1.17 |
| 52 Week High | $17.42 | $7.78 |
| Indicator | PROV | TMCI |
|---|---|---|
| Relative Strength Index (RSI) | 64.15 | 72.69 |
| Support Level | $16.91 | $2.46 |
| Resistance Level | $17.38 | $3.06 |
| Average True Range (ATR) | 0.20 | 0.26 |
| MACD | -0.01 | 0.06 |
| Stochastic Oscillator | 71.43 | 84.30 |
Provident Financial Holdings Inc is a holding company of Provident Savings Bank, F.S.B. It is a financial services company committed to serving consumers and small to mid-sized businesses in the Inland Empire region of Southern California. Its business activities consist of community banking, investment services and trustee services for real estate transactions. The group operates in Bank segment that include attracting deposits, offering banking services and originating and purchasing single-family, multi-family, commercial real estate, construction and, to a lesser extent, other mortgage, commercial business and consumer loans. Its evenues are derived from interest earned on its loan and investment portfolios, and fees generated through its community banking activities.
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers and hospitals.